Aker Biomarine AS (OL:AKBM) — Market Cap & Net Worth
Market Cap & Net Worth: Aker Biomarine AS (AKBM)
Aker Biomarine AS (OL:AKBM) has a market capitalization of $1.02 Billion (Nkr9.65 Billion) as of August 1, 2026. Listed on the OL stock exchange, this Norway-based company holds position #8693 globally and #66 in its home market, demonstrating a 3.38% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Aker Biomarine AS's stock price Nkr110.00 by its total outstanding shares 87703399 (87.70 Million). See Aker Biomarine AS capital spending ratio to understand how much of operating cash flow is reinvested back into capital assets.
Aker Biomarine AS Market Cap History: 2020 to 2026
Aker Biomarine AS's market capitalization history from 2020 to 2026. Data shows growth from $603.16 Million to $1.02 Billion (11.04% CAGR).
Aker Biomarine AS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Aker Biomarine AS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.11x
Aker Biomarine AS's market cap is 3.11 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.40x
Aker Biomarine AS's market cap is 3.40 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $603.16 Million | $288.59 Million | -$5.46 Million | 2.09x | N/A |
| 2021 | $278.74 Million | $262.06 Million | -$8.01 Million | 1.06x | N/A |
| 2022 | $195.32 Million | $277.20 Million | $10.00 Million | 0.70x | 19.53x |
| 2023 | $236.13 Million | $335.30 Million | -$8.90 Million | 0.70x | N/A |
| 2024 | $619.26 Million | $199.00 Million | $182.40 Million | 3.11x | 3.40x |
Competitor Companies of AKBM by Market Capitalization
Companies near Aker Biomarine AS in the global market cap rankings as of August 1, 2026.
Key companies related to Aker Biomarine AS by market ranking:
- Nestlé S.A (F:NESM): Ranked #83 globally with a market cap of $224.33 Billion USD ( €191.89 Billion EUR).
- Nestle S.A. (SW:NESN): Ranked #90 globally with a market cap of $214.29 Billion USD ( CHF169.50 Billion CHF).
- Danone SA (PA:BN): Ranked #523 globally with a market cap of $50.83 Billion USD ( €43.48 Billion EUR).
- Danone SA (F:BSND): Ranked #690 globally with a market cap of $39.05 Billion USD ( €33.40 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #83 | Nestlé S.A | F:NESM | $224.33 Billion | €88.20 |
| #90 | Nestle S.A. | SW:NESN | $214.29 Billion | CHF81.01 |
| #523 | Danone SA | PA:BN | $50.83 Billion | €67.52 |
| #690 | Danone SA | F:BSND | $39.05 Billion | €13.30 |
Aker Biomarine AS Historical Marketcap From 2020 to 2026
Between 2020 and today, Aker Biomarine AS's market cap moved from $603.16 Million to $ 1.02 Billion, with a yearly change of 11.04%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Nkr1.02 Billion | +11.45% |
| 2025 | Nkr910.89 Million | +47.09% |
| 2024 | Nkr619.26 Million | +162.25% |
| 2023 | Nkr236.13 Million | +20.89% |
| 2022 | Nkr195.32 Million | -29.93% |
| 2021 | Nkr278.74 Million | -53.79% |
| 2020 | Nkr603.16 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of Aker Biomarine AS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.02 Billion USD |
| MoneyControl | $1.02 Billion USD |
| MarketWatch | $1.02 Billion USD |
| marketcap.company | $1.02 Billion USD |
| Reuters | $1.02 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Aker Biomarine AS
Aker BioMarine ASA, a biotech innovator, develops and supplies krill-derived products for consumer health and wellness worldwide. It operates through three segments: Human Health Ingredients (HHI), Consumer Health Products, and Emerging Business. The Human Health Ingredients segment sells B2B krill oil supplements for humans under the Superba Krill brand; supplements for brain health under the LY… Read more